From: TMED3 promotes the development of malignant melanoma by targeting CDCA8 and regulating PI3K/Akt pathway
TMED3 expression
Tumor tissue
Para-carcinoma tissue
P value
Cases
Percentage
Low
80
47.9%
29
96.7%
P < 0.001
High
87
52.1%
1
3.3%